Takeda Pharmaceutical Co Ltd (TAK) EBIT Margin (2017 - 2026)
Takeda Pharmaceutical (TAK) recorded EBIT Margin of 16.51% in the quarter ended Jun 30, 2026, down 0.17 percentage points from 16.68% a year earlier and unchanged from the prior quarter.
Takeda Pharmaceutical Co Ltd (TAK) EBIT Margin (2017 - 2026) Analysis & Trends
On a TTM basis, Takeda Pharmaceutical's EBIT Margin came in at 5.83% as of Jun 30, 2026, down 4.55 percentage points year-over-year; for the year ended Mar 31, 2026, it came in at 0.14%, down 7.34 percentage points from the prior year.
- Annual EBIT Margin has a five-year change of -15.79 percentage points (years ended Mar 2021 to Mar 2026).
- Across earlier years, EBIT Margin came in at 7.48% in the year ended Mar 31, 2025 (+2.46 pp), 5.02% in the year ended Mar 31, 2024 (-7.16 pp), 12.18% in the year ended Mar 31, 2023 (-0.73 pp) and 12.91% in the year ended Mar 31, 2022 (-3.01 pp).
- Quarterly EBIT Margin has ranged from -38.03% in the quarter ended Dec 31, 2025 to 25.56% in the quarter ended Mar 31, 2022 over the past five years.
- On a year-over-year basis, EBIT Margin rose in four of the last eight quarters, with an average year-over-year change of -5.21 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 2.91 percentage points in the quarter ended Jun 30, 2025, against a drop of 30.92 percentage points in the quarter ended Dec 31, 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 16.51% (quarter ended Mar 31, 2026), -38.03% (quarter ended Dec 31, 2025) and 11.97% (quarter ended Sep 30, 2025).
Peer Comparison
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.51% |
| Mar 31, 2026 | 16.51% |
| Dec 31, 2025 | -38.03% |
| Sep 30, 2025 | 11.97% |
| Jun 30, 2025 | 16.68% |
| Mar 31, 2025 | 15.28% |
| Dec 31, 2024 | -7.11% |
| Sep 30, 2024 | 11.83% |
| Jun 30, 2024 | 13.77% |
| Mar 31, 2024 | 13.96% |
| Dec 31, 2023 | 8.43% |
| Sep 30, 2023 | 12.51% |
| Jun 30, 2023 | 15.92% |
| Mar 31, 2023 | 15.93% |
| Dec 31, 2022 | 13.40% |
| Sep 30, 2022 | 10.42% |
| Jun 30, 2022 | 15.48% |
| Mar 31, 2022 | 25.56% |
| Jun 30, 2021 | 26.17% |
| Mar 31, 2021 | 32.27% |
Takeda Pharmaceutical Co Ltd EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();